Course description
As predictions of the potential additional death toll from the COVID-19 pandemic due to cancer abound, many will query how great the anticipated wave of cancer claims in the years ahead will be, and how such cases are likely to be assessed.
This 1-hour webinar, presented by barrister Bella Webb, will consider the potential claims that may yet arise and the complexities they will entail.
Join Bella as she discusses the UK’s historic record in cancer management and survival, the potential categories of claims, including delays in existing treatment plans and lung cancer misdiagnosed as COVID-19, and expert evidence considerations, plus much more.
Upcoming start dates
Outcome / Qualification etc.
Training Course Content
Introduction
Clinical negligence claims dealing with cancer diagnosis and treatment are legally and often factually complex, and hugely emotive even during ‘normal’ times, both for Claimants and Defendants.
The COVID-19 pandemic ravaged the world and the NHS has rightly been praised for its heroic efforts in battling the virus, but the crisis has led to unique challenges resulting in medical decisions which may have profound implications for non-COVID patients over the months and years ahead.
As predictions of the potential additional death toll from the pandemic due to cancer abound, many will query how great the anticipated wave of cancer claims in the years ahead will be, and how such cases are likely to be assessed.
This webinar will consider the potential claims that may yet arise and the complexities that they will entail.
What You Will Learn
This webinar will cover the following:
- The UK’s historic record in cancer management and survival
- The predictions for excess deaths from cancer arising out of the COVID-19 pandemic
- COVID-19 NICE rapid guidelines for the delivery of systemic anti-cancer treatments and the Coronavirus Act 2020
- To what extent if at all, do resources matter when considering Bolam/Bolitho negligence?
- Potential categories of claims
- Delays in existing treatment plans
- Delayed or missed diagnoses/delayed screening
- Lung cancer misdiagnosed as COVID-19
- Expert evidence considerations
- A greater role for material contribution?
- Proposals for immunity for the NHS and health professionals against clinical negligence claims arising from the pandemic
Expenses
MBL Seminars Limited
MBL is a leading learning and development provider for professional service firms. Over the past 18 years, more than 198,000 people across 23,000 different organisations spanning 81 countries, have chosen us to deliver their training. With over 800 expert speakers...